You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BNT162b2

Showing 26 - 50 of 4,343
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in United States (drug, biological, other)

Active, not recruiting
  • COVID-19
  • Birmingham, Alabama
  • +21 more
Feb 2, 2023

SARS-CoV-2 Infection, COVID-19 Trial in Australia, New Zealand (BNT162b2, Placebo, Seasonal Inactivated Influenza Vaccine)

Completed
Has Results
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • +2 more
  • Brookvale, New South Wales, Australia
  • +25 more
Nov 22, 2023

Drug Use Investigation of COMIRNATY Intramuscular Injection

Active, not recruiting
  • COVID-19
  • BNT162b2
  • Tokyo, Japan
    PfizerLocal Country Office
Jan 9, 2023

SARS-CoV-2 Infection, COVID-19 Trial in Australia, New Zealand (BNT162b2, Placebo, Seasonal Inactivated Influenza Vaccine)

Completed
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • +2 more
  • Brookvale, New South Wales, Australia
  • +25 more
Nov 13, 2023

Vaccines, Adverse Effects, Injection Site Reaction Trial in Bursa (exercise)

Completed
  • Vaccines, Adverse Effects
  • Injection Site Reaction
  • exercise
  • Bursa, Turkey
    BursaYuksek Ihtisas Research and Training Hospital
Jan 8, 2022

BNT162b2 mRNA Covid-19 Vaccine in Brazil

Recruiting
  • Covid19
  • Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine
  • +3 more
  • Toledo, Paraná, Brazil
    Pronto Atendimento Municipal de Toledo
Dec 14, 2021

COVID-19 Trial in Vienna (Ad26COVS1, ChAdOx1 SARS2 Vaccine, BNT162B2)

Active, not recruiting
  • COVID-19
  • Vienna, Austria
    Medicial University of Vienna
Apr 12, 2022

Third Dose of SARS-CoV-2 Vaccine inCohort of Cancer Patients on

Recruiting
  • Sars-CoV-2 Infection
  • Three doses of BNT162b2 (observational)
  • Two doses of Coronavac and one dose BNT162b2 (observational)
  • Santiago, Chile
    Red de Salud UC Christus
Feb 1, 2022

COVID-19 Trial (GLB-COV2-043, BNT162b2/COMIRNATY®)

Not yet recruiting
  • COVID-19
  • (no location specified)
Oct 31, 2022

SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2)

Completed
Has Results
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • Anaheim, California
  • +20 more
Nov 30, 2022

SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2 (Omi XBB.1.5))

Not yet recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2 (Omi XBB.1.5)
  • Dublin, California
  • +14 more
Aug 10, 2023

Cancer Trial in Bronx (BNT162b2 vaccine)

Recruiting
  • Cancer
  • BNT162b2 vaccine
  • Bronx, New York
    Montefiore Medical Center
Dec 16, 2021

Covid19 Trial in Hong Kong (Tozinameran, CoronaVac, CoronaVac, intradermal)

Active, not recruiting
  • Covid19
  • Tozinameran
  • +2 more
  • Hong Kong, Hong Kong, China
    Queen Mary Hospital
Jul 14, 2022

Immune Response, Safety Trial in Incheon (bivalent BNT162b2 mRNA original/omicron BA.4-5 vaccine, quadrivalent influenza

Active, not recruiting
  • Immune Response
  • Safety
  • bivalent BNT162b2 mRNA original/omicron BA.4-5 vaccine
  • quadrivalent influenza vaccine
  • Incheon, Seo-gu, Korea, Republic of
    International St. Mary's hospital
Jul 28, 2023

Covid19 Trial (DelNS1-2019-nCoV-RBD-OPT1, Matching )

Not yet recruiting
  • Covid19
  • DelNS1-2019-nCoV-RBD-OPT1
  • Matching placebo
  • (no location specified)
Jan 20, 2022

SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2, BNT162b2.B.1.351)

Completed
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • BNT162b2.B.1.351
  • Oakland, California
  • +16 more
Feb 17, 2022

COVID-19 Trial in Melbourne (Tozinameran - Standard dose, Tozinameran - fractional dose, Elasomeran - standard dose)

Active, not recruiting
  • COVID-19
  • Tozinameran - Standard dose
  • +3 more
  • Melbourne, Victoria, Australia
    Royal Children's Hospital
Aug 24, 2022

COVID-19 Vaccination, Inflammation, Vaccine Immune Response Trial in Suwon, Seoul (either BNT162b2 or ChAdOx1 vaccine)

Recruiting
  • COVID-19 Vaccination
  • +3 more
  • either BNT162b2 or ChAdOx1 vaccine
  • Suwon, Gyeonggi-do, Korea, Republic of
  • +2 more
Apr 6, 2022

COVID-19 Trial in Bandung (Pfizer-BioNTech Standard dose, AstraZeneca Standard dose, Pfizer-BioNTech Fractional dose)

Not yet recruiting
  • COVID-19
  • Pfizer-BioNTech Standard dose
  • +5 more
  • Bandung, West Java, Indonesia
  • +2 more
Nov 30, 2022

Third Dose of COVID-19 Vaccine in Solid Organ Transplant

Completed
  • COVID-19
  • +3 more
  • Three doses of SARS-CoV-2 BNT162b2 vaccine (observational)
  • Two doses of CoronaVac and one dose of BNT162b2 SARS-CoV-2 vaccine (observational)
  • Santiago, Chile
    Pontificia Universidad Católica de Chile
Jan 3, 2022

Oxford-AstraZeneca COVID-19 Vaccine as2nd Booster,

Recruiting
  • COVID-19
  • ChAdOx1 nCOV-19 vaccine (Vaxzeria)
  • +3 more
  • São Paulo, Brazil
    Techtrials Pesquisa e Tecnologia Ltda.
Jan 23, 2023

Moderna COVID-19 Bivalent Booster for Omicron BA.4/5

Recruiting
  • COVID-19
  • Moderna COVID-19 Vaccine
  • +3 more
  • Culver City, California
    Science37
Mar 9, 2023

Chronic Kidney Diseases, COVID-19 Trial in Scarborough, Toronto (Pfizer-BioNTech COVID-19 Vaccine, MODERNA SARS-CoV-2 Vaccine)

Active, not recruiting
  • Chronic Kidney Diseases
  • COVID-19
  • Pfizer-BioNTech COVID-19 Vaccine
  • MODERNA SARS-CoV-2 Vaccine
  • Scarborough, Ontario, Canada
  • +2 more
Aug 5, 2022

Myocarditis Post Vaccination or Multi System Inflammatory

Recruiting
  • Myocarditis
  • No intervention
  • Jerusalem, Israel
    Hadassah Medical Center
Mar 18, 2022

Community-based Sero-epidemiological Study of COVID-19

Active, not recruiting
  • COVID-19
  • mRNA BNT162b2 vaccine
  • CoronaVac vaccine
  • Hong Kong, Hong Kong
    The University of Hong Kong
Oct 28, 2022